Our team recently published that the FL-NPM1 component of NPM-ALK binds to FoxM1, an oncogenic transcriptional factor, thereby promoting its DNA binding, transcriptional activity, and oncogenic potential in ALK+ALCL cells [20]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.